Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials-Reference-Cited by-同舟云学术

Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials

Published:2019-01 Issue:1 Volume:5 Page:354-363
ISSN:2352-8737
Container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions
language:en
Short-container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions

Author:

Andrews J. Scott¹,Desai Urvi²,Kirson Noam Y.²,Zichlin Miriam L.²,Ball Daniel E.¹,Matthews Brandy R.¹

Affiliation:

1. Eli Lilly and Company, Lilly Corporate CenterIndianapolisINUSA

2. Analysis Group, Inc.BostonMAUSA

Funder

National Institute on Aging

National Institutes of Health

Eli Lilly and Company

NIA

NIH

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.trci.2019.06.005

Reference19 articles.

1. Systematic Review of Measures of Clinical Significance Employed in Randomized Controlled Trials of Drugs for Dementia

2. A point of minimal important difference (MID): a critique of terminology and methods

3. Measurement of health status

4. Green Park Collaborative Evidence guidance document: design of clinical studies of pharmacologic therapies for Alzheimer's disease Center for Medical Technology Policy.2013. Available at:http://www.cmtpnet.org/docs/resources/GPC_Evidence_Guidance_Document_‐_Alzheimers_Disease.pdf. Accessed September 10 2018.

5. L.Webster D.Groskreutz A.Grinbergs‐Saull R.Howard J.T.O'Brien andG.Mountain et al.Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: systematic review and consensus recommendations 2017. Available at:https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0179521 2017Accessed September 10 2018.

Cited by 206 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects silymarin and rosuvastatin on amyloid-carriers level in dyslipidemic Alzheimer’s patients: A double-blind placebo-controlled randomized clinical trial;IBRO Neuroscience Reports;2024-12

2. The impact of education level and socioeconomic status on the association between depressive symptoms and memory in an older population in Latin America: An exploratory analysis from the Brazilian Longitudinal Study of Aging (ELSI-BRAZIL);Dialogues in Health;2024-12

3. Dietary patterns, inflammatory biomarkers and cognition in older adults: An analysis of three population-based cohorts;Clinical Nutrition;2024-10

4. Physical frailty predicts cognitive decline among community-dwelling older Japanese women: A prospective cohort study from the Otassha study;Archives of Gerontology and Geriatrics;2024-09

5. Examination of the proportion and characteristics of cognitive function changes during hospitalization in patients with cardiovascular diseases;PLOS ONE;2024-08-22